Medication Overview In December 2013, the U.S. Food and Drug Administration approved two new drugs from a new class of drugs which help fight chronic hepatitis C infection: Olysio (generic name simeprevir, made by Janssen) and Sovaldi (generic name sofosbuvir, made by Gilead). Olysio is called a protease inhibitor, since it blocks a key viral
Read More